Bioceres Crop Solutions Corp (BIOX)
12.98
-0.20
(-1.48%)
USD |
NASDAQ |
May 10, 12:15
Bioceres Crop Solutions Research and Development Expense (Quarterly): 3.643M for Dec. 31, 2023
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 3.643M |
| September 30, 2023 | 4.581M |
| June 30, 2023 | 4.142M |
| March 31, 2023 | 3.894M |
| December 31, 2022 | 3.458M |
| September 30, 2022 | 3.852M |
| June 30, 2022 | 2.296M |
| March 31, 2022 | 1.836M |
| December 31, 2021 | 1.384M |
| September 30, 2021 | 1.432M |
| Date | Value |
|---|---|
| June 30, 2021 | 2.035M |
| March 31, 2021 | 1.443M |
| December 31, 2020 | 1.115M |
| September 30, 2020 | 1.024M |
| June 30, 2020 | 0.8036M |
| March 31, 2020 | 1.264M |
| December 31, 2019 | 0.9236M |
| September 30, 2019 | 1.204M |
| June 30, 2019 | 1.599M |
| March 31, 2019 | 1.147M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
0.8036M
Minimum
Jun 2020
4.581M
Maximum
Sep 2023
2.207M
Average
1.599M
Median
Jun 2019